Society of Nuclear Medicine and Molecular Imaging Announces 2022 Fellows

June 22, 2022 — The Society of Nuclear Medicine and Molecular Imaging recognized 15 new SNMMI Fellows on Monday, June 13, during a plenary session at the society’s 2022 Annual Meeting, held June 11-14. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members. 

All past SNMMI presidents were granted Fellowship at the 2016 Annual Meeting. Now SNMMI’s 2021-22 president, Richard Wahl, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, has joined their ranks. Also recognized were: 

Abass Alavi, MD, Hospital of the University of Pennsylvania, University of Pennsylvania; Philadelphia, Pennsylvania

Johannes Czernin, MD, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Farrokh Dehdashti, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Yuni Dewaraja, PhD, University of Michigan Medical School, Ann Arbor, Michigan

Cameron Foster, MD, University of California Davis Health, Sacramento, California

Warren Janowitz, MD, JD, Radiology Associates of South Florida, Baptist Health, Miami, Florida

Neeta Pandit-Taskar, MD, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York

Daniel Pryma, MD, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania

Lalitha Shankar, MD, PhD, National Cancer Institute, Bethesda, Maryland

John Sunderland, PhD, University of Iowa, University of Iowa Carver College of Medicine, Iowa City, Iowa)

Jerold Wallis, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Dean Wong, MD, PhD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Anna Wu, PhD, Beckman Research Institute of City of Hope, Duarte, California

Katherine Zukotynski, MD, PhD, Peng, McMaster University, Hamilton, Canada

Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.

For more information: www.snmmi.org

Find more SNMMI22 coverage here


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now